Estimating prevalence of fetal alcohol syndrome (FAS): Effectiveness of a passive birth defects registry system

被引:13
|
作者
Fox, DJ [1 ]
Druschel, CM [1 ]
机构
[1] New York State Dept Hlth, Congenital Malformat Registry, Troy, NY 12180 USA
关键词
D O I
10.1002/bdra.10108
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
BACKGROUND: Fetal alcohol syndrome (FAS) is a preventable birth defect, easiest to recognize in children two through eleven years and more difficult to recognize in newborns. In New York State, two systems ascertain FAS cases, the statewide birth defects registry and the Fetal Alcohol Syndrome Surveillance Network (FASSNet) system. The accuracy of FAS reports to the birth defects registry was assessed through a comparison with the FASSNet system. METHODS: The birth defects registry mandates reporting up to age two, including FAS with an ICD-9 code of 760.71. FASSNet is a population-based, multi-source surveillance and uses a standard definition to determine FAS case status. RESULTS: Among 33 children reported to the registry with FAS, 19 (58%) met FASSNet criteria for FAS. FASSNet identified 24 additional children with FAS facial features documented before the child's second birthday that should have been reported to the birth defects registry. FAS prevalence rate for the birth defects registry was 0.28 per 1,000 live births but would have been 0.37 if all children diagnosed before age two were included. CONCLUSIONS: Almost 60% of children reported to a birth defects registry with FAS from 1995 to 1998 were confirmed as FAS based on a more intensive surveillance. Additional children with FAS were not reported to the CMR. FAS prevalence calculated from birth defects registries, relying on the ICD-9 code 760.71, include false positives and underestimate the true prevalence. Age limits for reporting FAS to registries further contribute to under ascertainment. Birth Defects Research (Part A) 67:604-608, 2003. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:604 / 608
页数:5
相关论文
共 50 条
  • [31] NEURAL TUBE DEFECTS WITH FETAL ALCOHOL SYNDROME
    FUSTER, JS
    GUELL, S
    CAHUANA, AB
    GARCIATORNEL, S
    [J]. JOURNAL OF PEDIATRICS, 1979, 95 (02): : 328 - 329
  • [32] The FAS Screen: a rapid screening tool for fetal alcohol syndrome
    Burd, L
    Cox, C
    Poitra, B
    Ebertowski, M
    Martsolf, JT
    Kerbeshian, J
    Klug, MG
    [J]. ADDICTION BIOLOGY, 1999, 4 (03) : 329 - +
  • [33] EDUCATION OF A CHILD WITH FETAL ALCOHOL SYNDROME (FAS) - A CHALLENGE FOR A TEACHER
    Banach, Marek
    Matejek, Jozefa
    [J]. EDULEARN19: 11TH INTERNATIONAL CONFERENCE ON EDUCATION AND NEW LEARNING TECHNOLOGIES, 2019, : 1589 - 1595
  • [34] NEUROTRANSMITTER DEVELOPMENT IN A FETAL ALCOHOL SYNDROME (FAS) MOUSE MODEL
    SCHAMBRA, UB
    SULIK, KK
    PETRUSZ, P
    LAUDER, JM
    [J]. TERATOLOGY, 1987, 35 (02) : A40 - A40
  • [35] ETHANOL IS THE PROXIMATE TERATOGEN OF THE MOUSE FETAL ALCOHOL SYNDROME (FAS)
    MATHINOS, PR
    SCOTT, WJ
    [J]. TERATOLOGY, 1982, 25 (02) : A61 - A61
  • [36] Using facial images to diagnose fetal alcohol syndrome (FAS)
    Huang, J
    Jain, A
    Fang, SF
    Riley, EP
    [J]. ITCC 2005: International Conference on Information Technology: Coding and Computing, Vol 2, 2005, : 66 - 71
  • [37] Formic acid A neurotoxin associated with fetal alcohol syndrome(FAS)
    Kapur, BM
    Vandenbroucke, AC
    Adamchik, A
    Lathotay, DC
    Carlen, PL
    [J]. THERAPEUTIC DRUG MONITORING, 2003, 25 (04) : 493 - 493
  • [38] EEG-EXAMINATIONS BY CHILDREN WITH FETAL ALCOHOL SYNDROME (FAS)
    SPOHR, HL
    MAJEWSKI, F
    NOLTE, R
    [J]. EPILEPSIA, 1980, 21 (02) : 202 - 202
  • [39] RENAL MANIFESTATIONS OF FETAL ALCOHOL SYNDROME (FAS) IN HUMANS AND ANIMALS
    DEBEUKELAER, MM
    RANDALL, CL
    BOGGAN, WO
    SMITH, RM
    [J]. KIDNEY INTERNATIONAL, 1977, 12 (06) : 465 - 465
  • [40] Issues in estimating the prevalence of fetal alcohol syndrome: Examination of 2 counties in New York state
    Druschel, Charlotte M.
    Fox, Deborah J.
    [J]. PEDIATRICS, 2007, 119 (02) : E384 - E390